EUVIMEDEUVIMED entdecken
Open Access

Persistent Splenomegaly Is Associated with Morbidity in Tanzanian Children with Sickle Cell Anemia: Secondary Analysis of the SPHERE Trial

Emmanuela E Ambrose, George Tomlinson, Patrick S Ngoya, Susan E Stuber, Teresa S Latham, Russell E Ware, Abel N Makubi, Luke R Smart

Acta Haematologica · 28.04.2026 · 1-11

DOI: 10.1159/000552026 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Haematologica, online erschienen am 28.04.2026. Verfasst von Emmanuela E Ambrose und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatrics and Child Health, Catholic University of Health and Allied Sciences, Mwanza, Tanzania, emmanuelaambrose@gmail.com. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

African children with sickle cell anemia (SCA) often have splenomegaly with recurrent cytopenias that complicate management, rather than the splenic atrophy typically observed in SCA.

Methods

We analyzed the presence, persistence, and impact of splenomegaly in the Stroke Prevention with Hydroxyurea Enabled through Research and Education (SPHERE) trial (NCT03948867), an open-label trial of dose-escalated hydroxyurea to prevent stroke in Tanzanian children with SCA. Palpable splenomegaly was recorded at each visit. Annual ultrasound measurements were compared to age- and height-related references. Longitudinally, palpable splenomegaly was categorized as infrequent (present in 50% visits). Adverse events (AEs) and hydroxyurea dose-limiting toxicities (DLTs) were compared using incidence rate ratios (IRRs) among the three categories.

Results

At enrollment, splenomegaly was identified in 48/196 (25%) by palpation and 78 (40%) by ultrasound. Across 221 patient-years of treatment in 53 children, splenomegaly was intermittent in 19% and persistent in 21%. At 12 months, children with persistent splenomegaly were compared to those with infrequent splenomegaly and had achieved similar hydroxyurea dose (23.1 vs. 27.6 mg/kg/day, p = 0.136), hemoglobin (9.0 vs. 9.1 g/dL, p = 0.877), and HbF (23.8 vs. 24.3%, p = 0.481), but experienced more vaso-occlusive AE (IRR = 3.8, p value 0.122), transfusions (IRR = 7.1, p value 0.014), and DLTs (IRR = 3.2, p value 0.073).

Conclusion

Splenomegaly is common in Tanzanian children with SCA, often persistent, worsens clinical outcomes, and complicates hydroxyurea. Its cause remains unclear, and further investigation is urgently needed to clarify its etiology, improve its management, and ensure optimal hydroxyurea treatment.

Schlagwörter

Stichwörter der Autor:innen

AfricaChildrenHydroxyureaSickle cell anemiaSpleen

Autor:innen und Institutionen

  • Department of Paediatrics and Child Health, Catholic University of Health and Allied Sciences, Mwanza, Tanzania, emmanuelaambrose@gmail.com.
  • Department of Paediatrics and Child Health, Bugando Medical Centre, Mwanza, Tanzania, emmanuelaambrose@gmail.com.
  • Institute for Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.
  • Toronto General Hospital Research Institute, Toronto, Ontario, Canada.
  • Department of Radiology, Catholic University of Health and Allied Sciences, Mwanza, Tanzania.
  • Division of Hematology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Ambrose, E. E., Tomlinson, G., Ngoya, P. S., Stuber, S. E., Latham, T. S., Ware, R. E., Makubi, A. N., & Smart, L. R. (2026). Persistent Splenomegaly Is Associated with Morbidity in Tanzanian Children with Sickle Cell Anemia: Secondary Analysis of the SPHERE Trial. Acta Haematologica, 1-11. https://doi.org/10.1159/000552026

Vancouver

Ambrose EE, Tomlinson G, Ngoya PS, Stuber SE, Latham TS, Ware RE, et al. Persistent Splenomegaly Is Associated with Morbidity in Tanzanian Children with Sickle Cell Anemia: Secondary Analysis of the SPHERE Trial. Acta Haematologica. 2026:1-11. doi:10.1159/000552026

BibTeX
@article{Ambrose2026,
  author = {Ambrose, Emmanuela E and Tomlinson, George and Ngoya, Patrick S and Stuber, Susan E and Latham, Teresa S and Ware, Russell E and Makubi, Abel N and Smart, Luke R},
  title = {Persistent Splenomegaly Is Associated with Morbidity in Tanzanian Children with Sickle Cell Anemia: Secondary Analysis of the SPHERE Trial},
  journal = {Acta Haematologica},
  year = {2026},
  pages = {1--11},
  doi = {10.1159/000552026}
}
Kostenlos starten →